Endotelix: Funding, Investors & Team (Sep 2026)
Endotelix is an independent biotechnology startup located in Switzerland, created from the University of Geneva. They have a strong commitment to developing efficient solutions for Antiphospholipid Syndrome, such as swift diagnostic testing and effective treatment choices.
Endotelix has raised $100k across 1 funding round on record, the most recent an undisclosed round of $100k announced in Mar 2023.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Endotelix Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Endotelix Funding Rounds
Endotelix Founders and Leadership Team
Contact details for the Endotelix team: 1 of 1 has an email address on file.
Start 14-day free trial →Endotelix Funding Compared to Other Health Care Startups
Endotelix's latest round of $100k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Endotelix in Health Care and Plan-les-ouates
Companies Similar to Endotelix
MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.
CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…
Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…
UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…
Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…
Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…
Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…
Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…
Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…
Endotelix Funding FAQs
What does Endotelix do?
Endotelix is an independent biotechnology startup located in Switzerland, created from the University of Geneva. They have a strong commitment to developing efficient solutions for Antiphospholipid Syndrome, such as swift diagnostic testing and effective treatment choices.
How much funding has Endotelix raised?
Endotelix has raised $100k across 1 round on record. The most recent is an undisclosed round of $100k announced in Mar 2023.
When did Endotelix last raise funding?
Endotelix's most recent funding round on record is an undisclosed round of $100k, announced in Mar 2023.
Who is the CEO of Endotelix?
Karim Brandt is listed as CEO at Endotelix.
Where is Endotelix headquartered?
Endotelix is based in Plan-les-ouates, Geneve, Switzerland.
How many employees does Endotelix have?
Endotelix is in the 1-10 employee band.
How does Endotelix's funding compare to other Health Care startups?
Endotelix's latest round of $100k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Endotelix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Endotelix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.